The Centers for Medicare & Medicaid Services today posted the final incentive payment adjustment factors for the fiscal year 2017 Hospital Value-Based Purchasing Program, which are being used to adjust base operating Medicare Severity Diagnosis-Related Group payments to eligible hospitals for discharges this year. As required by law, base operating MS-DRG payments to eligible inpatient prospective payment system hospitals are being reduced by 2% in FY 2017 to fund an estimated $1.8 billion in incentive payments for the VBP program. The actual VBP amount earned by each hospital depends on its Total Performance Score and incentive payment percentage. 鈥淎fter taking into account the statutorily mandated 2% withhold, the highest performing hospital in FY 2017 will receive a net increase in payments of slightly more than 4%, and the lowest performing hospital will incur a net reduction of 1.83%,鈥 CMS . To view the final FY 2017 adjustment factors, see Table 16B at .

Related News Articles

Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride鈥
Headline
The Food and Drug Administration has identified a Class I recall of Q鈥橝pel Medical 072 Aspiration System after the company submitted three device event reports鈥
Headline
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and鈥
Headline
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections鈥
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue鈥
Headline
The incidence of invasive group A strep infections increased from 3.6 to 8.2 cases per 100,000 people from 2013 to 2022, according to a study authored by the鈥